All Publications Citing Use of MCE Products

• ACS Appl Mater Interfaces. 2019 Jan 16;11(2):1766-1781. CY5-SE purchased from MCE.

• ACS Appl Mater Interfaces. 2018 Sep 12;10(36):30081-30091. Hoechst 33342, Cell Counting Kit-8 purchased from MCE.

• ACS Appl Mater Interfaces.  2018 Aug 8;10(31):26128-26141. Heparin sodium salt purchased from MCE.

• ACS Appl Mater Interfaces. 2018 Jun 6;10(22):18560-18573. Combretastatin A4 purchased from MCE.

• ACS Appl Mater Interfaces. 2018 Mar 28;10(12):9916-9928. Phosphatase Inhibitor Cocktail II purchased from MCE.

• ACS Appl Mater Interfaces. 2018 Feb 21;10(7):6180-6189. Deferoxamine mesylate purchased from MCE.

• ACS Appl Mater Interfaces. 2017 Dec 13;9(49):42544-42555. GANT 61 purchased from MCE.

• ACS Appl Mater Interfaces. 2017 Apr 12;9(14):12195-12202. Vemurafenib, Sorafenib purchased from MCE.

• Cancer Immunol Res. 2021 Jun 30. Asunaprevir, Grazoprevir purchased from MCE.

• Cancer Immunol Res. 2021 Apr 10;canimm.0968.2020. BLZ945, SBE-β-CD purchased from MCE.

• Cancer Immunol Res. 2021 Apr 19. THZ1 purchased from MCE.

• Cancer Immunol Res. 2020 Dec 10. Trametinib purchased from MCE.

• Cancer Immunol Res. 2020 Dec;17(12):1269-1271. MRS 2578 purchased from MCE.

• Cancer Immunol Res. 2020 Nov;8(11):1426-1439. Cisplatin, AS1517499, A 438079 hydrochloride purchased from MCE.

• Cancer Immunol Res. 2020 Apr;8(4):436-450. GSK2795039 purchased from MCE.

• Cancer Immunol Res. 2016 Jun;4(6):520-30. Momelotinib purchased from MCE.

• Cancer Immunol Res. 2015 Aug;3(8):864-70. SCH 546738 purchased from MCE.

• Bioact Mater. 1 July 2021. PD 169316, Defactinib hydrochloride purchased from MCE.

• Bioact Mater. 2021 Jun 1. Src Inhibitor 1, Verteporfin, EHT 1864, Y-27632, Defactinib hydrochloride, NSC 23766 purchased from MCE.

• Bioact Mater. 6 (2021) 4073-4082. Verapamil, SKF-96365 hydrochloride purchased from MCE.

• Bioact Mater. 6 (2021) 2158-2172. Exo1, Indoximod, Genistein purchased from MCE.

• Bioact Mater. 6 (2021) 2039-2057. Plerixafor, J-113863, TAK-220, SB225002, Ki8751, CCR3 antagonist 1, Cyclo(-RGDfK) purchased from MCE.

• Bioact Mater. 6 (2021) 2372-2389. Rapamycin purchased from MCE.

• Bioact Mater. 2020 Oct 26;6(4):1175-1188. DMOG purchased from MCE.

• Bioact Mater. 2020 Mar 30;5(2):398-409. Thiazolyl Blue purchased from MCE.

• Cell Syst. 2020 Nov 18;11(5):478-494.e9. PD0325901, SHP099, Trametinib, Selumetinib, Dabrafenib, Vemurafenib, LY3009120, Lapatinib, Cobimetinib, Erlotinib, Bemcentinib, Binimetinib, AZ 628 purchased from MCE.

• Cell Syst. 2020 Jan 22;10(1):66-81.e11. Buparlisib, ZSTK474, AZ20, Trametinib, Rabusertib, Dactolisib, AS-605240, Everolimus, AZD 6482, Pilaralisib analogue, TGX-221, Alpelisib, BX-912, Idelalisib, MK-2206 dihydrochloride, Apitolisib, PI-103, AZD-8055, Rapamycin, WYE-132, Omipalisib, PIK-93, Torin 2 purchased from MCE.

• Cell Syst. 2019 Jul 24;9(1):35-48.e5. Neratinib, Trametinib, Linsitinib, Alpelisib, Paclitaxel, Palbociclib, Etoposide, Vorinostat purchased from MCE.

• Cell Syst. 2018 Apr 25;6(4):424-443.e7. Belinostat, PD0325901, EPZ005687, SP600125, Tacrolimus, Dactolisib, RO4929097, Selumetinib, Verteporfin, RGFP966, Everolimus, Vemurafenib, Losmapimod, Alpelisib, EPZ004777, Duvelisib, BMS-345541 hydrochloride, Nilotinib, Pazopanib, Molibresib, KN-93, OSI-027, Pinometostat, CC-401, Rapamycin, LY294002, Seliciclib, Geldanamycin, TBB, Selisistat, Semagacestat, Palbociclib, Niclosamide, Sotrastaurin, Lenalidomide, Momelotinib, Fedratinib, Etoposide, Ruxolitinib, KN-62, Olaparib, Menin-MLL inhibitor MI-2, GSK126, Afuresertib, CPI-169, KU-55933, UNC1215, SCH900776, Tofacitinib, I-BET151, Pravastatin sodium, Flavopiridol, Curcumin, BIX-01294, AR-A014418, Dinaciclib purchased from MCE.

• Leukemia. 2021 Jun 1. 5-Azacytidine purchased from MCE.

• Leukemia. 2021 Mar 29. Cytarabine, Regorafenib, Vincristine sulfate purchased from MCE.

• Leukemia. 2021 Mar 8. Miltefosine, Trilostane purchased from MCE.

• Leukemia. 2021 Feb 1. CGI-1746, Fenebrutinib, RN486 purchased from MCE.

• Leukemia. 2021 Jan 27. SCH772984 purchased from MCE.

• Leukemia. 2020 Jun;34(6):1524-1539. Dasatinib purchased from MCE.

• Leukemia. 2020 May;34(5):1241-1252. Skp2 Inhibitor C1, SZL P1-41 purchased from MCE.

• Leukemia. 2019 Aug;33(8):1964-1977. Itacitinib, Filgotinib purchased from MCE.

• Leukemia. 2019 Jul;33(7):1675-1686. CB-5083, Ricolinostat purchased from MCE.

• Leukemia. 2019 Jun;33(6):1373-1386. Luminespib, CHZ868 purchased from MCE.

• Leukemia. 2017 Oct;31(10):2037-2047. (+)-JQ-1 purchased from MCE.

• Leukemia. 2016 Jan;30(1):173-81. Ibrutinib purchased from MCE.

• Leukemia. 2015 Jan;29(1):169-76. Idelalisib purchased from MCE.

• Leukemia. 2014 Sep;28(9):1819-27. Dactolisib purchased from MCE.

• Leukemia. 2012 Oct;26(10):2233-44. Quizartinib, Saracatinib, Pyridone 6, Momelotinib, Ruxolitinib, Dasatinib, AZD-1480 purchased from MCE.

• Theranostics. 2021 May 13;11(14):7110-7125. SB-431542, SIS3 free base purchased from MCE.

• Theranostics. 2021 Jun 1;11(15):7491-7506. Brefeldin A, Flubendazole purchased from MCE.

• Theranostics. 2021 May 24;11(15):7308-7321. R406, Genistein purchased from MCE.

• Theranostics. 2021 Apr 15;11(13):6278-6292. Cisplatin purchased from MCE.

• Theranostics. 2021 Apr 19;11(13):6355-6369. Rapamycin purchased from MCE.

• Theranostics. 2021 Mar 24;11(12):5650-5674. Cisplatin, PKA Inhibitor Fragment (6-22) amide TFA, Glucosamine, Aminooxyacetic acid hemihydrochloride, Paclitaxel, Gemcitabine, H-89, Rp-cAMPS, Osimertinib, EGTA purchased from MCE.